| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | NAD+-protein-cysteine ADP-ribosyltransferase activity | 6.76e-05 | 6 | 43 | 2 | GO:0140803 | |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | 6.50e-07 | 358 | 43 | 8 | GO:0000398 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 6.50e-07 | 358 | 43 | 8 | GO:0000377 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | 7.07e-07 | 362 | 43 | 8 | GO:0000375 | |
| GeneOntologyBiologicalProcess | RNA splicing | 7.53e-07 | 502 | 43 | 9 | GO:0008380 | |
| GeneOntologyBiologicalProcess | regulation of mRNA processing | 8.86e-07 | 158 | 43 | 6 | GO:0050684 | |
| GeneOntologyBiologicalProcess | mRNA processing | 1.63e-06 | 551 | 43 | 9 | GO:0006397 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA splicing, via spliceosome | 2.09e-06 | 44 | 43 | 4 | GO:0048026 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA processing | 3.24e-06 | 49 | 43 | 4 | GO:0050685 | |
| GeneOntologyBiologicalProcess | regulation of RNA splicing | 4.25e-06 | 207 | 43 | 6 | GO:0043484 | |
| GeneOntologyBiologicalProcess | regulation of mRNA splicing, via spliceosome | 7.04e-06 | 129 | 43 | 5 | GO:0048024 | |
| GeneOntologyBiologicalProcess | positive regulation of RNA splicing | 8.92e-06 | 63 | 43 | 4 | GO:0033120 | |
| GeneOntologyBiologicalProcess | mRNA metabolic process | 9.40e-05 | 917 | 43 | 9 | GO:0016071 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA metabolic process | 9.57e-05 | 115 | 43 | 4 | GO:1903312 | |
| GeneOntologyBiologicalProcess | sensory perception of mechanical stimulus | 1.32e-04 | 238 | 43 | 5 | GO:0050954 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA metabolic process | 1.96e-04 | 259 | 43 | 5 | GO:1903313 | |
| GeneOntologyBiologicalProcess | protein auto-ADP-ribosylation | 2.31e-04 | 11 | 43 | 2 | GO:0070213 | |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | 2.95e-04 | 443 | 43 | 6 | GO:1903311 | |
| GeneOntologyBiologicalProcess | cellular response to follicle-stimulating hormone stimulus | 4.38e-04 | 15 | 43 | 2 | GO:0071372 | |
| GeneOntologyBiologicalProcess | glial cell differentiation | 5.25e-04 | 321 | 43 | 5 | GO:0010001 | |
| GeneOntologyBiologicalProcess | ventricular cardiac muscle tissue development | 5.34e-04 | 76 | 43 | 3 | GO:0003229 | |
| GeneOntologyBiologicalProcess | mRNA stabilization | 5.54e-04 | 77 | 43 | 3 | GO:0048255 | |
| GeneOntologyBiologicalProcess | lung morphogenesis | 5.54e-04 | 77 | 43 | 3 | GO:0060425 | |
| GeneOntologyBiologicalProcess | neuron remodeling | 7.88e-04 | 20 | 43 | 2 | GO:0016322 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA catabolic process | 7.92e-04 | 87 | 43 | 3 | GO:1902373 | |
| GeneOntologyBiologicalProcess | RNA stabilization | 8.19e-04 | 88 | 43 | 3 | GO:0043489 | |
| GeneOntologyBiologicalProcess | embryonic digestive tract morphogenesis | 8.69e-04 | 21 | 43 | 2 | GO:0048557 | |
| GeneOntologyBiologicalProcess | response to follicle-stimulating hormone | 8.69e-04 | 21 | 43 | 2 | GO:0032354 | |
| GeneOntologyBiologicalProcess | cellular response to gonadotropin stimulus | 9.55e-04 | 22 | 43 | 2 | GO:0071371 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 9.61e-04 | 93 | 43 | 3 | GO:0086003 | |
| GeneOntologyBiologicalProcess | skeletal muscle cell differentiation | 1.05e-03 | 96 | 43 | 3 | GO:0035914 | |
| GeneOntologyCellularComponent | nuclear body | GATA4 HMBOX1 ABHD17A PARP11 SCAF11 SRSF4 THRAP3 SRSF8 MBD1 SETBP1 DHX9 | 1.49e-06 | 903 | 43 | 11 | GO:0016604 |
| Domain | RRM_1 | 3.09e-06 | 208 | 37 | 6 | PF00076 | |
| Domain | RRM | 3.95e-06 | 217 | 37 | 6 | SM00360 | |
| Domain | RRM_dom | 5.12e-06 | 227 | 37 | 6 | IPR000504 | |
| Domain | RRM | 5.52e-06 | 230 | 37 | 6 | PS50102 | |
| Domain | - | 7.74e-06 | 244 | 37 | 6 | 3.30.70.330 | |
| Domain | Nucleotide-bd_a/b_plait | 1.06e-05 | 258 | 37 | 6 | IPR012677 | |
| Domain | WWE | 2.49e-04 | 12 | 37 | 2 | PS50918 | |
| Domain | WWE-dom | 2.49e-04 | 12 | 37 | 2 | IPR004170 | |
| Domain | WWE | 2.49e-04 | 12 | 37 | 2 | PF02825 | |
| Domain | Poly(ADP-ribose)pol_cat_dom | 5.10e-04 | 17 | 37 | 2 | IPR012317 | |
| Domain | PARP_CATALYTIC | 5.10e-04 | 17 | 37 | 2 | PS51059 | |
| Domain | PARP | 5.10e-04 | 17 | 37 | 2 | PF00644 | |
| Domain | - | 5.10e-04 | 17 | 37 | 2 | 3.90.228.10 | |
| Domain | TyrKc | 6.99e-04 | 88 | 37 | 3 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 6.99e-04 | 88 | 37 | 3 | IPR020635 | |
| Domain | PROTEIN_KINASE_TYR | 9.28e-04 | 97 | 37 | 3 | PS00109 | |
| Domain | Tyr_kinase_AS | 9.28e-04 | 97 | 37 | 3 | IPR008266 | |
| Domain | RRM_dom_euk | 9.41e-04 | 23 | 37 | 2 | IPR003954 | |
| Domain | RRM_1 | 9.41e-04 | 23 | 37 | 2 | SM00361 | |
| Domain | WGR_domain | 1.03e-03 | 24 | 37 | 2 | IPR008893 | |
| Domain | SH2 | 1.04e-03 | 101 | 37 | 3 | PF00017 | |
| Domain | SH2 | 1.33e-03 | 110 | 37 | 3 | SM00252 | |
| Domain | SH2 | 1.37e-03 | 111 | 37 | 3 | PS50001 | |
| Domain | SH2 | 1.41e-03 | 112 | 37 | 3 | IPR000980 | |
| Domain | - | 1.41e-03 | 112 | 37 | 3 | 3.30.505.10 | |
| Domain | Pkinase_Tyr | 2.11e-03 | 129 | 37 | 3 | PF07714 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 2.55e-03 | 138 | 37 | 3 | IPR001245 | |
| Domain | VWA | 5.50e-03 | 56 | 37 | 2 | PF00092 | |
| Domain | DEAD | 9.19e-03 | 73 | 37 | 2 | PF00270 | |
| Domain | DEAD/DEAH_box_helicase_dom | 9.19e-03 | 73 | 37 | 2 | IPR011545 | |
| Domain | IGv | 9.68e-03 | 75 | 37 | 2 | SM00406 | |
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | 8.76e-07 | 258 | 44 | 6 | 37794589 | |
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 18562473 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 30674417 | ||
| Pubmed | Preferential conduction block of myelinated axons by nitric oxide. | 1.56e-06 | 2 | 44 | 2 | 27614087 | |
| Pubmed | 3.07e-06 | 723 | 44 | 8 | 34133714 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 15256532 | ||
| Pubmed | CIRBP GATA4 DDX3Y SCAF11 ZNF326 RBMXL3 DSP THRAP3 SRSF8 PARP12 | 6.39e-06 | 1371 | 44 | 10 | 36244648 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 6.87e-06 | 807 | 44 | 8 | 22681889 | |
| Pubmed | 9.37e-06 | 4 | 44 | 2 | 7760813 | ||
| Pubmed | 1.42e-05 | 244 | 44 | 5 | 29884807 | ||
| Pubmed | 1.45e-05 | 245 | 44 | 5 | 35652658 | ||
| Pubmed | Unproductive splicing of SR genes associated with highly conserved and ultraconserved DNA elements. | 2.34e-05 | 6 | 44 | 2 | 17361132 | |
| Pubmed | 2.34e-05 | 6 | 44 | 2 | 10501972 | ||
| Pubmed | A HIV-1 Tat mutant protein disrupts HIV-1 Rev function by targeting the DEAD-box RNA helicase DDX1. | 2.58e-05 | 45 | 44 | 3 | 25496916 | |
| Pubmed | 2.69e-05 | 136 | 44 | 4 | 21280222 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 2.91e-05 | 1294 | 44 | 9 | 30804502 | |
| Pubmed | Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk. | 3.27e-05 | 7 | 44 | 2 | 20062064 | |
| Pubmed | Sip1, a novel RS domain-containing protein essential for pre-mRNA splicing. | 3.27e-05 | 7 | 44 | 2 | 9447963 | |
| Pubmed | 3.43e-05 | 731 | 44 | 7 | 29298432 | ||
| Pubmed | 4.26e-05 | 153 | 44 | 4 | 28225217 | ||
| Pubmed | TRAP150 activates pre-mRNA splicing and promotes nuclear mRNA degradation. | 4.36e-05 | 8 | 44 | 2 | 20123736 | |
| Pubmed | 4.36e-05 | 8 | 44 | 2 | 17515609 | ||
| Pubmed | SR protein-specific kinase 1 is highly expressed in testis and phosphorylates protamine 1. | 4.36e-05 | 8 | 44 | 2 | 10390541 | |
| Pubmed | Regulation of alternative splicing by SRrp86 and its interacting proteins. | 5.27e-05 | 57 | 44 | 3 | 14559993 | |
| Pubmed | PABP1 identified as an arginine methyltransferase substrate using high-density protein arrays. | 5.60e-05 | 9 | 44 | 2 | 11850402 | |
| Pubmed | Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. | 5.73e-05 | 327 | 44 | 5 | 15592455 | |
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | 5.98e-05 | 330 | 44 | 5 | 33301849 | |
| Pubmed | 6.99e-05 | 10 | 44 | 2 | 18596238 | ||
| Pubmed | 7.58e-05 | 347 | 44 | 5 | 16033648 | ||
| Pubmed | 8.47e-05 | 844 | 44 | 7 | 25963833 | ||
| Pubmed | Mutations in C1orf194, encoding a calcium regulator, cause dominant Charcot-Marie-Tooth disease. | 8.54e-05 | 11 | 44 | 2 | 31199454 | |
| Pubmed | 8.73e-05 | 1153 | 44 | 8 | 29845934 | ||
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | 8.89e-05 | 583 | 44 | 6 | 29844126 | |
| Pubmed | A collagen VI-dependent pathogenic mechanism for Hirschsprung's disease. | 1.02e-04 | 12 | 44 | 2 | 26571399 | |
| Pubmed | 1.02e-04 | 12 | 44 | 2 | 28949961 | ||
| Pubmed | 1.02e-04 | 12 | 44 | 2 | 26678830 | ||
| Pubmed | 1.02e-04 | 12 | 44 | 2 | 36402907 | ||
| Pubmed | Expression of laminin receptors in schwann cell differentiation: evidence for distinct roles. | 1.02e-04 | 12 | 44 | 2 | 12843252 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 1.09e-04 | 605 | 44 | 6 | 28977666 | |
| Pubmed | 1.10e-04 | 73 | 44 | 3 | 24728074 | ||
| Pubmed | 1.15e-04 | 74 | 44 | 3 | 33989516 | ||
| Pubmed | CNS myelin paranodes require Nkx6-2 homeoprotein transcriptional activity for normal structure. | 1.21e-04 | 13 | 44 | 2 | 15601927 | |
| Pubmed | Genomic structure and chromosomal mapping of the murine and human Mbd1, Mbd2, Mbd3, and Mbd4 genes. | 1.21e-04 | 13 | 44 | 2 | 10441743 | |
| Pubmed | WAVE1 is required for oligodendrocyte morphogenesis and normal CNS myelination. | 1.21e-04 | 13 | 44 | 2 | 16723544 | |
| Pubmed | 1.21e-04 | 13 | 44 | 2 | 15688026 | ||
| Pubmed | A rational nomenclature for serine/arginine-rich protein splicing factors (SR proteins). | 1.21e-04 | 13 | 44 | 2 | 20516191 | |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | 1.25e-04 | 621 | 44 | 6 | 22794259 | |
| Pubmed | 1.27e-04 | 203 | 44 | 4 | 35012549 | ||
| Pubmed | 1.29e-04 | 77 | 44 | 3 | 22973453 | ||
| Pubmed | 1.45e-04 | 80 | 44 | 3 | 16094384 | ||
| Pubmed | 1.50e-04 | 1247 | 44 | 8 | 27684187 | ||
| Pubmed | 1.62e-04 | 83 | 44 | 3 | 11114734 | ||
| Pubmed | 1.63e-04 | 15 | 44 | 2 | 10790433 | ||
| Pubmed | Sox9 overexpression exerts multiple stage-dependent effects on mouse spinal cord development. | 1.63e-04 | 15 | 44 | 2 | 31724774 | |
| Pubmed | 1.73e-04 | 220 | 44 | 4 | 24550385 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 1.81e-04 | 954 | 44 | 7 | 36373674 | |
| Pubmed | Regulation of ubiquitin-proteasome system-mediated Tip110 protein degradation by USP15. | 1.86e-04 | 16 | 44 | 2 | 24984263 | |
| Pubmed | 1.86e-04 | 16 | 44 | 2 | 11071635 | ||
| Pubmed | Family-wide analysis of poly(ADP-ribose) polymerase activity. | 1.86e-04 | 16 | 44 | 2 | 25043379 | |
| Pubmed | 1.86e-04 | 87 | 44 | 3 | 29991678 | ||
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | 1.89e-04 | 670 | 44 | 6 | 22990118 | |
| Pubmed | DBIRD complex integrates alternative mRNA splicing with RNA polymerase II transcript elongation. | 1.99e-04 | 89 | 44 | 3 | 22446626 | |
| Pubmed | A quantitative protein interaction network for the ErbB receptors using protein microarrays. | 2.06e-04 | 90 | 44 | 3 | 16273093 | |
| Pubmed | TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | 2.06e-04 | 430 | 44 | 5 | 38172120 | |
| Pubmed | 2.19e-04 | 234 | 44 | 4 | 36243803 | ||
| Pubmed | 2.38e-04 | 239 | 44 | 4 | 26641092 | ||
| Pubmed | An integrated genetic map of the pearl locus of mouse chromosome 13. | 2.64e-04 | 19 | 44 | 2 | 8828042 | |
| Pubmed | 2.64e-04 | 713 | 44 | 6 | 29802200 | ||
| Pubmed | 2.78e-04 | 249 | 44 | 4 | 9371744 | ||
| Pubmed | 2.87e-04 | 251 | 44 | 4 | 31076518 | ||
| Pubmed | 2.93e-04 | 20 | 44 | 2 | 12447396 | ||
| Pubmed | 3.28e-04 | 260 | 44 | 4 | 36199071 | ||
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 3.32e-04 | 477 | 44 | 5 | 31300519 | |
| Pubmed | 3.56e-04 | 22 | 44 | 2 | 17084361 | ||
| Pubmed | 3.56e-04 | 22 | 44 | 2 | 37298108 | ||
| Pubmed | 3.61e-04 | 109 | 44 | 3 | 29511296 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 3.88e-04 | 1082 | 44 | 7 | 38697112 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 4.09e-04 | 774 | 44 | 6 | 15302935 | |
| Pubmed | 4.23e-04 | 115 | 44 | 3 | 17332742 | ||
| Pubmed | 4.24e-04 | 24 | 44 | 2 | 25344368 | ||
| Pubmed | ERp57 is essential for efficient folding of glycoproteins sharing common structural domains. | 4.61e-04 | 25 | 44 | 2 | 17170699 | |
| Pubmed | 4.61e-04 | 25 | 44 | 2 | 15121898 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | 4.96e-04 | 1489 | 44 | 8 | 28611215 | |
| Pubmed | Quantitative-trait loci analysis of cocaine-related behaviours and neurochemistry. | 4.99e-04 | 26 | 44 | 2 | 10591541 | |
| Pubmed | 5.38e-04 | 27 | 44 | 2 | 23471215 | ||
| Pubmed | 5.79e-04 | 28 | 44 | 2 | 18067320 | ||
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 6.04e-04 | 130 | 44 | 3 | 35545047 | |
| Pubmed | 6.18e-04 | 131 | 44 | 3 | 28634551 | ||
| Pubmed | 6.39e-04 | 551 | 44 | 5 | 34728620 | ||
| Pubmed | 6.46e-04 | 133 | 44 | 3 | 15144186 | ||
| Pubmed | 6.57e-04 | 847 | 44 | 6 | 35850772 | ||
| Pubmed | 6.89e-04 | 136 | 44 | 3 | 26979993 | ||
| Pubmed | A global genomic transcriptional code associated with CNS-expressed genes. | 6.98e-04 | 318 | 44 | 4 | 16919269 | |
| Pubmed | 7.19e-04 | 138 | 44 | 3 | 30320910 | ||
| Pubmed | 7.57e-04 | 32 | 44 | 2 | 23154389 | ||
| Pubmed | Elucidation of the BMI1 interactome identifies novel regulatory roles in glioblastoma. | 7.92e-04 | 329 | 44 | 4 | 34316702 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 8.17e-04 | 582 | 44 | 5 | 20467437 | |
| Pubmed | 8.38e-04 | 334 | 44 | 4 | 30425250 | ||
| Pubmed | The PRMT5/WDR77 complex regulates alternative splicing through ZNF326 in breast cancer. | 8.63e-04 | 147 | 44 | 3 | 28977470 | |
| Pubmed | 9.06e-04 | 35 | 44 | 2 | 10984455 | ||
| Interaction | SRSF3 interactions | 4.74e-06 | 522 | 38 | 8 | int:SRSF3 | |
| Interaction | SNRPC interactions | 1.58e-05 | 440 | 38 | 7 | int:SNRPC | |
| Interaction | BMI1 interactions | 2.57e-05 | 659 | 38 | 8 | int:BMI1 | |
| Interaction | SNRPA interactions | 2.85e-05 | 482 | 38 | 7 | int:SNRPA | |
| Interaction | EPHB3 interactions | 3.88e-05 | 35 | 38 | 3 | int:EPHB3 | |
| Interaction | PRMT8 interactions | 4.32e-05 | 104 | 38 | 4 | int:PRMT8 | |
| Interaction | SNRPF interactions | 7.70e-05 | 385 | 38 | 6 | int:SNRPF | |
| Interaction | TAF15 interactions | 1.06e-04 | 408 | 38 | 6 | int:TAF15 | |
| GeneFamily | RNA binding motif containing | 5.27e-05 | 213 | 35 | 5 | 725 | |
| GeneFamily | RNA binding motif containing|Serine and arginine rich splicing factors | 2.37e-04 | 12 | 35 | 2 | 737 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 4.86e-04 | 17 | 35 | 2 | 684 | |
| GeneFamily | SH2 domain containing | 9.73e-04 | 101 | 35 | 3 | 741 | |
| GeneFamily | Immunoglobulin heavy locus at 14q32.33 | 5.59e-03 | 187 | 35 | 3 | 349 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 7.30e-03 | 206 | 35 | 3 | 682 | |
| ToppCell | COPD-Epithelial-Aberrant_Basaloid|COPD / Disease state, Lineage and Cell class | 2.26e-05 | 176 | 42 | 4 | 11d867bcb4f2471b4e13a5f7dc1c24286197f26d | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-05 | 176 | 42 | 4 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | AT1-AT2_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 2.26e-05 | 176 | 42 | 4 | f86832cfeff5b3cfffe4455c1b96a1420d48ba1e | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.31e-05 | 177 | 42 | 4 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.31e-05 | 177 | 42 | 4 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.41e-05 | 179 | 42 | 4 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | droplet-Marrow-BM|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-05 | 181 | 42 | 4 | 4169a1527b9c8f5783b8cc44e3a3924f8ed9a5e2 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.52e-05 | 181 | 42 | 4 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_dim-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.86e-05 | 187 | 42 | 4 | 0bca79cea4886b66350c56c61859bd71e1e7a85c | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.98e-05 | 189 | 42 | 4 | 0e8d1be3c406d1a393e18faccfe89116a8f82bcf | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-05 | 189 | 42 | 4 | 2a5fda73d38bdc23cf47e5335ffd4e086e990245 | |
| ToppCell | IPF-Epithelial-Aberrant_Basaloid|World / Disease state, Lineage and Cell class | 2.98e-05 | 189 | 42 | 4 | 8030a353473da34ae92429f2d822171a2e94248f | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-05 | 190 | 42 | 4 | 96a92212ea3fb35fa3d0da495e504edc61c71c23 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_NK|Lung / Manually curated celltypes from each tissue | 3.23e-05 | 193 | 42 | 4 | a98ee519e0da93ae4a2dcdda1ee8b4138dec131b | |
| ToppCell | COVID-19_Severe-CD8+_T_activated|World / disease group, cell group and cell class | 3.23e-05 | 193 | 42 | 4 | ddc1db516568e03be8e82b2ca770c67756418185 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-05 | 194 | 42 | 4 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_NK-NK_CD16|Lung / Manually curated celltypes from each tissue | 3.30e-05 | 194 | 42 | 4 | 3337042eef91a49f621058785723228cf4dfdad4 | |
| ToppCell | Control-Stromal-Myofibroblast|Control / Disease state, Lineage and Cell class | 3.37e-05 | 195 | 42 | 4 | ffcf76cd72e43d8cf1058a49c76e0956065038bc | |
| ToppCell | droplet-Marrow-BM-1m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.37e-05 | 195 | 42 | 4 | 637b06ef3967b03f7165d102d316e8b7161a817d | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.57e-05 | 198 | 42 | 4 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-gd_T|URO / Disease, condition lineage and cell class | 3.57e-05 | 198 | 42 | 4 | cb584f7754ef4e6d9ec7155022852f2d2676ab4f | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-05 | 198 | 42 | 4 | b086af292a508a156266c2d899ba1caf820bf61c | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.57e-05 | 198 | 42 | 4 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.64e-05 | 199 | 42 | 4 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | COVID-19_Severe-CD8+_T_activated|COVID-19_Severe / disease group, cell group and cell class | 3.64e-05 | 199 | 42 | 4 | a16b961996291bd5958c3851b7fdd7b45c53e19b | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 3.72e-05 | 200 | 42 | 4 | b0ba486b55be18a4236bd2644f02352651f4b1fe | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.72e-05 | 200 | 42 | 4 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_large-bowel / Manually curated celltypes from each tissue | 3.94e-04 | 152 | 42 | 3 | 95944864ce7539ff8de028f5700694931338f3ff | |
| ToppCell | Club_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 4.02e-04 | 153 | 42 | 3 | 77030b0e033f3635b1bbe7552a28c074ea7bb106 | |
| ToppCell | AT1-AT2_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 4.41e-04 | 158 | 42 | 3 | 3bc51cfd37b289cc3e866b54ce55a298e5eff690 | |
| ToppCell | COPD-Epithelial-Aberrant_Basaloid|Epithelial / Disease state, Lineage and Cell class | 4.41e-04 | 158 | 42 | 3 | 8f66979e92f886d86cecbd26aaa0c5915c049734 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_D|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.66e-04 | 161 | 42 | 3 | b60b4fd34a3ad4bf1813e6cc24aa7e04f9e53e4c | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 4.75e-04 | 162 | 42 | 3 | 810881210e015c788814e4fe8d7a24c929cf2621 | |
| ToppCell | normal-na-Lymphocytic_NK-NK_bright-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 4.92e-04 | 164 | 42 | 3 | b5a91f2cbfad9a2bc38aea576085a37865df955d | |
| ToppCell | Basal_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 5.27e-04 | 168 | 42 | 3 | 48089fa2d4a0f31a72405717119b767a92571f01 | |
| ToppCell | 15-Airway-Epithelial-Submucosal_gland_basal|Airway / Age, Tissue, Lineage and Cell class | 5.46e-04 | 170 | 42 | 3 | 61f8dd5e27df1b8d01ccfd0d25247b34aa8d182c | |
| ToppCell | tumor_Lung-Endothelial_cells-EPCs|Endothelial_cells / Location, Cell class and cell subclass | 5.55e-04 | 171 | 42 | 3 | dcb6c41980008d0b9eeb54999faff77311554976 | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_4|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 5.55e-04 | 171 | 42 | 3 | 7c8304573b892ef9ea4e048cba9ea9fbab848dcd | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-T_cells-T-cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.55e-04 | 171 | 42 | 3 | 539ea88acc6f948efdeae8b69e5c5ffaee29f1d9 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.55e-04 | 171 | 42 | 3 | c3e3ea09c73050372314a89b282e36ba5f339d73 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|390C / Donor, Lineage, Cell class and subclass (all cells) | 5.55e-04 | 171 | 42 | 3 | d6d8ea45b443d95f64720c9bc07d324148f5b239 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.65e-04 | 172 | 42 | 3 | 6c17a1e586a72d1bd80c20c06370429c61dc9f85 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Granulocytic-Basophil|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.65e-04 | 172 | 42 | 3 | 6503e85182eb6e8a40a890e393e9ac5c5350e322 | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-T_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.65e-04 | 172 | 42 | 3 | 0fc692be845d4225ff8b63bf9195724fc8510c2c | |
| ToppCell | 390C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.65e-04 | 172 | 42 | 3 | 84d16cd7f618c94888920680bdc9e7130d73fd75 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.65e-04 | 172 | 42 | 3 | 3c0bf7200e582ee730af49dcd86446e112226aca | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.74e-04 | 173 | 42 | 3 | fde1fabb8d13d05998ac3f21ecb1fde6a7a2f337 | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-iNKT/MAIT|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.74e-04 | 173 | 42 | 3 | dcde3252ff96448d3a61039a4948c74ad321a218 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Basal-Basal-Basal_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.84e-04 | 174 | 42 | 3 | 97d4a40b536a67fa52f055eab26106d041bf3220 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Basal-Basal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.84e-04 | 174 | 42 | 3 | f9f399244c7d12caf8118ec3117d477a39e35c3b | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-iNKT/MAIT|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.84e-04 | 174 | 42 | 3 | 61aa89b56ebda0eba1ba675d5f036992967f670f | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Basal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.84e-04 | 174 | 42 | 3 | e8440eea7c81864defa57c89e9b569ad8033e5c5 | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.94e-04 | 175 | 42 | 3 | 98cb577df466700e72d1bbc6689205ccf2e7fcba | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-mature_enterocytic-Paneth|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.94e-04 | 175 | 42 | 3 | bffa623511ceb0b9bf76d87f9a10cfadfe0e940f | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT-T_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.04e-04 | 176 | 42 | 3 | bb41e9478373726eb460af764de0277b2d09928e | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT-T_cells-T-cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.04e-04 | 176 | 42 | 3 | 9d4a4dfeebb5a8a0f3ab18c37c8ddc2cd2158575 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)|390C / Donor, Lineage, Cell class and subclass (all cells) | 6.04e-04 | 176 | 42 | 3 | 852d3da0907fe87c0ef23d75a63ce07619cf0c54 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 6.04e-04 | 176 | 42 | 3 | d2df1e435996c51213e88270af9f928e9e09a6f5 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.14e-04 | 177 | 42 | 3 | 7617270f49cd6b7ba66db72d20560cee985012b2 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.14e-04 | 177 | 42 | 3 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.14e-04 | 177 | 42 | 3 | f1efd9c3074d5635700fe7fbebf3dd0b1e0a84f1 | |
| ToppCell | COPD-Epithelial-Aberrant_Basaloid|World / Disease state, Lineage and Cell class | 6.14e-04 | 177 | 42 | 3 | 22b7cda748cf5e665be54ca5bae89f0c130d5e7f | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-M/X_cells_(MLN/GHRL+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.14e-04 | 177 | 42 | 3 | c80893e5cf5688ee9f5afc8f11b3890f296c9e1f | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.24e-04 | 178 | 42 | 3 | 41745a589567ca5ea6d06331f4c8da03595b5f5c | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-GHRL+_NE_precursor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.24e-04 | 178 | 42 | 3 | 32cc4155267baf1b536a61310044e6502d09531f | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT-iNKT/MAIT|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.24e-04 | 178 | 42 | 3 | 7905621f5b2aa55324c5592d1d2fef763a5fa41f | |
| ToppCell | facs-Heart-RA-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.24e-04 | 178 | 42 | 3 | b505e2550860e777535ee95f29c936242fd607f1 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.24e-04 | 178 | 42 | 3 | eb940dd64c973f68bcaad6069d3bd56383329db5 | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.24e-04 | 178 | 42 | 3 | f914092c20130207193f97c6044ae61a9a440a86 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.34e-04 | 179 | 42 | 3 | 7c8a2fa1326c73dc9e774df645b572864fd97133 | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.34e-04 | 179 | 42 | 3 | ecea75c568911ff56939c9f67ab901497bd4356c | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.34e-04 | 179 | 42 | 3 | 5ccf0824611ded5c673d94dff3048aedac12f1a8 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.45e-04 | 180 | 42 | 3 | 935c091bbcd6d10b81dc4731779e5bd98205c99f | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.45e-04 | 180 | 42 | 3 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 | |
| ToppCell | AT1-AT2_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 6.45e-04 | 180 | 42 | 3 | 3c7b2033821f9e34e2924bd8655f566edcbcc7d3 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.45e-04 | 180 | 42 | 3 | 8bf6e8b6b45ce42f8c5f23e7cd1752ec8b3fa2d2 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_NK-NK_bright-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.55e-04 | 181 | 42 | 3 | 4795833e0ec49287bd7809ecfe523fc527565fba | |
| ToppCell | -Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 6.55e-04 | 181 | 42 | 3 | ef579e958f334da0f9415aa7e3d5c02c807954a6 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_NK-NK_bright|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.55e-04 | 181 | 42 | 3 | 208cdccc2f0d0f2d8ec321064c63aed206d46c32 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-04 | 181 | 42 | 3 | c26d3cbbc592299786d79d1b15fc6bead2aafb9a | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.66e-04 | 182 | 42 | 3 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-T_cells-NK_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.66e-04 | 182 | 42 | 3 | feda21c92d30848de70c8b404eaabbca3f5e894d | |
| ToppCell | pdx-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 6.66e-04 | 182 | 42 | 3 | 7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee | |
| ToppCell | Control-Epithelial-Basal|Control / Disease state, Lineage and Cell class | 6.66e-04 | 182 | 42 | 3 | caddd0a52f0234ea6a916186ffaf2454cdcd80ee | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.66e-04 | 182 | 42 | 3 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | severe_influenza-gd_T|severe_influenza / disease group, cell group and cell class (v2) | 6.66e-04 | 182 | 42 | 3 | b6b44c90af3f0c0dddb2b171087865d8c15a3973 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.76e-04 | 183 | 42 | 3 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.76e-04 | 183 | 42 | 3 | cc7f5a17b40e8d901885174922e5fa8877643071 | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMK+-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 6.76e-04 | 183 | 42 | 3 | 79defd22b3194dad16db55b9bdd220c09c1e6b90 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.76e-04 | 183 | 42 | 3 | ff6dde877659cde9daa3263db0932c9c9ef1adac | |
| ToppCell | B_cells-ISG-high_B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 6.76e-04 | 183 | 42 | 3 | dc2b00e920efa1dcc2a6265cd1024e3249c9974f | |
| ToppCell | Control-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.76e-04 | 183 | 42 | 3 | 2c5707ada3442eb7100a2a5f9438d5a2ac53a9e1 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.76e-04 | 183 | 42 | 3 | 803376f5260de83c48d4f7301278d078a32b3e6e | |
| ToppCell | (7)_Epithelial-H_(AT1)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.87e-04 | 184 | 42 | 3 | 1f76b37c265b519171b767a52d48f31f0cdc4a3c | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_neural-B|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.87e-04 | 184 | 42 | 3 | cd2919dc8e90d03f57eb43f59f7da9bcd676496e | |
| ToppCell | tumor_Lung-Fibroblasts-Mesothelial_cells|tumor_Lung / Location, Cell class and cell subclass | 6.87e-04 | 184 | 42 | 3 | b0a251030d127858e68cf164be158f209a4d720f | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.87e-04 | 184 | 42 | 3 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D122|Adult / Lineage, Cell type, age group and donor | 6.87e-04 | 184 | 42 | 3 | 2b7e6f91e11c228f0521e099886867d9e998e78d | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.87e-04 | 184 | 42 | 3 | 42cadfdb5d29a50bd7e901ddd14d42b39e8474f0 | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMH+-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 6.98e-04 | 185 | 42 | 3 | 097d628f92e13250c15b550f2fd1f4225fc07558 | |
| Disease | tyrosine-protein kinase TEC measurement | 1.02e-05 | 4 | 39 | 2 | EFO_0020830 | |
| Disease | cystathionine measurement | 2.87e-04 | 19 | 39 | 2 | EFO_0010474 | |
| Disease | myositis | 1.22e-03 | 39 | 39 | 2 | EFO_0000783 | |
| Disease | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement | 1.47e-03 | 170 | 39 | 3 | EFO_0000685, EFO_0007791, EFO_0007837 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DSDGELGSRYSSGYS | 126 | Q5XKK7 | |
| DYSGYGASSGRPSER | 146 | Q96GS6 | |
| CGDYYIGGRRFSSLS | 236 | P20936 | |
| YREGSARYAFSFSGA | 161 | Q96GW7 | |
| TYDDRAYSSFGGGRG | 6 | Q15056 | |
| SGGSTYYADSRKGRF | 71 | A0A0C4DH36 | |
| SGGSTYYADSRKGRF | 71 | P0DTE1 | |
| FGRRSSYGGSSYGNS | 61 | Q6NT76 | |
| FRKSGATCGRSDTYY | 21 | Q9UIS9 | |
| RKTYFGGGTASAYLA | 286 | Q96EN8 | |
| YRKSAGGFIHGFRYT | 391 | Q8IWF2 | |
| SDTYAYRLLSGGGRS | 71 | P58499 | |
| KYAYSAASGGRRSAT | 261 | P17301 | |
| YSAYVTASTRFGDGK | 961 | Q9UMZ3 | |
| VHGTSYGKGSYFARD | 586 | Q9H0J9 | |
| FGKGTYFARDAAYSS | 231 | Q9NR21 | |
| REQYGRAGFAGSYSS | 146 | P43694 | |
| GYVTRFYREASSGAA | 921 | P12109 | |
| TSGGGGTSRMYYSRR | 31 | P15924 | |
| RRGSFDATGNSSYSY | 2846 | P15924 | |
| RYRDHFAAGGYSSLG | 946 | P29322 | |
| YGGRASDYKSAHKGF | 261 | P02686 | |
| RTTSDGGYSFKYETV | 341 | P05111 | |
| SFGSRDSRGKPGYFS | 71 | O15523 | |
| KAVFFSRGSSFRYSG | 331 | O94887 | |
| GNRGRGTYRSSFAYK | 1076 | Q99590 | |
| RYDNGSGYRRGGSSY | 1166 | Q08211 | |
| YSGGSTYYADSVKGR | 71 | P01767 | |
| ATSGAGGGSRLYYSF | 301 | P35716 | |
| SGRSGYGYRRSGRDK | 81 | Q08170 | |
| YTKFGGEGSSGFRHY | 286 | P42680 | |
| RESRYGGSHYSSSGY | 181 | Q9BRL6 | |
| GGRDSYSSSYGRSDR | 321 | O75526 | |
| RSGGYGGSRDYYSSR | 131 | Q14011 | |
| LGADDSYYTARSAGK | 486 | P43403 | |
| SAASGGAAYTKRYLE | 336 | Q9Y2W1 | |
| YTYSSGNKEDGRFTA | 71 | A0A0B4J271 | |
| SFSNSYGRSDHYGRG | 896 | Q8N7X1 | |
| SSIKSYGLSDRYGGG | 966 | Q8N7X1 | |
| RRYAGKDSDAFGGYG | 101 | Q9BSK1 | |
| RSSYSGYSGYSQGSR | 611 | Q9UQD0 | |
| GYSGYSQGSRSSRIF | 616 | Q9UQD0 | |
| TKTNDYGYCSGGSRS | 161 | Q9BXE9 | |
| SGSKRRSYEGFGTYR | 1296 | Q9Y6X0 | |
| SRFGGSYGGRFESSY | 101 | Q5BKZ1 | |
| SYGGRFESSYRNSLD | 106 | Q5BKZ1 | |
| RRGGYEYSDQKSGKS | 366 | Q9BRK3 |